News

Patients living with Crohn’s and colitis to benefit from £5m grant for a new data research hub based in Cambridge

£5m grant awarded by Health Data Research UK (HDR UK) to establish a health data research hub for inflammatory bowel disease (IBD) following a successful bid led by Eastern AHSN and Cambridge Read more

A life of low cholesterol and BP slashes heart and circulatory disease risk

Modest and sustained decreases in blood pressure and cholesterol levels reduces the lifetime risk of developing fatal heart and circulatory diseases, such as heart attack and stroke, according to research. Read more

World Health Organisation CVD risk charts updated using Cambridge-led research

Research revising the World Health Organisation (WHO) cardiovascular disease (CVD) risk prediction charts to aid efforts to reduce the burden of CVD, especially in low- and middle-income countries, has been published by The Lancet Global Health.Read more

New stem cell combination could help to repair damaged hearts

A combination of heart cells derived from human stem cells could be the answer to developing a desperately-needed treatment for heart failure, according to new research part-funded by the British Heart Foundation (BHF), Read more

No microbiome in human placenta: Cambridge researchers’ paper published in Nature

World-leading science journal Nature has published a paper from the Department of Obstetrics and Gynaecology at the University of Cambridge. Entitled “Human placenta has no microbiome but can contain potential pathogens”, the paper Read more

Cambridge University Hospitals revealed as country’s top performing trust for increasing research

Cambridge University Hospitals NHS Foundation Trust (CUH) has been revealed as England’s top performing trust for increasing research in the annual National Institute for Health Research Read more

Cambridge researchers take top awards

Two NIHR Cambridge BRC researchers have won top awards from the The American Diabetes Association. Read more

Study shows that in HER2 positive early breast cancer 6 months treatment with Herceptin is as good as 12 months for preventing cancer return

NIHR Cambridge BRC and CRUK breast cancer study could help patients and save millions of pounds worldwide.Read more

World-leading genome study spells hope for sick babies

A Cambridge-based study has shown that the diagnosis and treatment of some of the most critically ill babies can be improved by sequencing their whole genome.Read more

Virtual reality can spot navigation problems in early Alzheimer’s disease

Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, suggests new research.Read more

Additional routine ultrasounds benefit mothers and babies, and could save costs, study finds

A study led by researchers at the University of Cambridge and published this week in PLOS Medicine has found that offering universal late pregnancy ultrasounds at 36 weeks’ gestation eliminates Read more

Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines

Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge.Read more

Discover more

If you would like more information about the NIHR Cambridge BRC, please contact us.